Tissuemed is a medical device developer and manufacturer based in Leeds, UK.
 | |
| Company type | Private |
|---|---|
| Industry | Medical Devices |
| Headquarters | Leeds, West Yorkshire, U.K. |
| Products | TissuePatch product family of surgical sealant films |
| Website | www.tissuemed.com |
The company was founded in 1985 and developed the first tissue heart valve to receive regulatory approval in Europe. This business was divested in 1999 and Tissuemed focused on the development of tissue adhesives for surgical use.
After five years of research, Tissuemed launched TissuePatch, a range of surgical sealant films for the prevention of leaks during surgery, including thoracic, general and neurosurgery.[1][2][3]
References
- ^ Ferroli, P (2013 Mar-Apr). "A novel impermeable adhesive membrane to reinforce dural closure: a preliminary retrospective study on 119 consecutive high-risk patients". World neurosurgery. 79 (3–4): 551–7. PMID 22120260.
{{cite journal}}: Check date values in:|date=(help); Unknown parameter|coauthors=ignored (|author=suggested) (help) - ^ von der Brelie, C (2012 Apr). "Intraoperative sealing of dura mater defects with a novel, synthetic, self adhesive patch: application experience in 25 patients". British journal of neurosurgery. 26 (2): 231–5. PMID 22077588.
{{cite journal}}: Check date values in:|date=(help); Unknown parameter|coauthors=ignored (|author=suggested) (help) - ^ Della Puppa, A (2010 Oct). "Use of a new absorbable sealing film for preventing postoperative cerebrospinal fluid leaks: remarks on a new approach". British journal of neurosurgery. 24 (5): 609–11. PMID 20868249.
{{cite journal}}: Check date values in:|date=(help); Unknown parameter|coauthors=ignored (|author=suggested) (help)